Bristol Myers Squibb
Sustainability Report and Carbon Intensity Rankings
Is Bristol Myers Squibb doing their part?
Their DitchCarbon score is 52
Bristol Myers Squibb has a DitchCarbon Score of 52, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, which is a measure of how much carbon emissions are produced relative to their activity. A higher score would suggest a lower carbon intensity and a stronger commitment to reducing their environmental impact.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Bristol Myers Squibb operates in the health and social services industry, which has a carbon intensity ranking of low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Bristol Myers Squibb operates in the United States, which has a low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by reducing its carbon footprint.
Unlock 30+ emissions data points on Bristol Myers Squibb
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Bristol Myers Squibb
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
10.44%
...this company is doing 10.44% better in emissions than the industry average.
Bristol-Myers Squibb, founded in 1887 and headquartered in the United States, operates in the biopharmaceutical industry. The company specializes in the discovery, development, and delivery of innovative medicines for serious and life-threatening diseases, including oncology and cardiovascular conditions. Additionally, through the Bristol-Myers Squibb Foundation, it works to promote health equity and improve outcomes for populations affected by serious health challenges.
emission intelligence's platform recommendations for Bristol Myers Squibb
Bristol Myers Squibb should set clear, science-driven targets for reducing their Scope 3 emissions and consistently report on their progress while promoting sustainable practices throughout their supply chain, potentially decreasing emissions by 35%.
Good news, Bristol Myers Squibb has embraced SBTi commitments
Bristol Myers Squibb has pledged to set science-based targets through the Science Based Targets initiative (SBTi) to reduce greenhouse gas emissions in line with climate science. This commitment signifies the company’s dedication to sustainability and aligning its operations with the global effort to limit warming and mitigate climate change impacts.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.